Takeuchi, S.; Hanakita, J.; Takahashi, T.; Inoue, T.; Minami, M.; Suda, I.; Nakamura, S.; Kanematsu, R.
Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. Medicina 2023, 59, 268.
https://doi.org/10.3390/medicina59020268
AMA Style
Takeuchi S, Hanakita J, Takahashi T, Inoue T, Minami M, Suda I, Nakamura S, Kanematsu R.
Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. Medicina. 2023; 59(2):268.
https://doi.org/10.3390/medicina59020268
Chicago/Turabian Style
Takeuchi, Shu, Junya Hanakita, Toshiyuki Takahashi, Tomoo Inoue, Manabu Minami, Izumi Suda, Sho Nakamura, and Ryo Kanematsu.
2023. "Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868" Medicina 59, no. 2: 268.
https://doi.org/10.3390/medicina59020268
APA Style
Takeuchi, S., Hanakita, J., Takahashi, T., Inoue, T., Minami, M., Suda, I., Nakamura, S., & Kanematsu, R.
(2023). Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. Medicina, 59(2), 268.
https://doi.org/10.3390/medicina59020268
